Meine Merkliste  

364 Aktuelle Marktstudien von Business Monitor International


Sie können Ihre Recherche weiter verfeinern. Wählen Sie aus dem linken Bereich passende Suchfilter aus, um Ihre Ergebnisse gezielt einzugrenzen.

Israel Pharmaceuticals and Healthcare Report Q1 2012

BMI View: Our opinion that industrial action in Israel would result in an increase in public healthcare expenditure has played out. The government is promising an additional ILS2.7bn (US$764mn) a year for doctors’ salaries and public health in general. This is a significantly larger increase than ...


Germany Pharmaceuticals and Healthcare Report Q1 2012

BMI View: We view Germany as the fifth most attractive pharmaceutical market globally. A large population and the government’s contribution to healthcare funding will continue to support absolute pharmaceutical values. However, patent expirations and the need for cost-containment in healthcare ...


Indonesia Pharmaceuticals and Healthcare Report Q1 2012

BMI View: Indonesia will continue to represent a high-risk but high-reward pharmaceutical market for multinationals, on account of its deficient regulatory and intellectual property (IP) environment on one hand, and the large and fast-growing population and economy, on the other. Nevertheless, ...


Serbia Pharmaceuticals and Healthcare Report Q1 2012

BMI View: Despite a downgrade in our economic outlook for Serbia, BMI's expenditure projections for the pharmaceutical market for 2012-2015 are up moderately due to revisions to our previous expectation that drugmakers will take action to reduce their exposure in the market because of the ...


Seite 37 von 37
Suche per e-Mail abonnieren

Sie erhalten passend zu Ihrer Suche die neusten Suchergebnisse per E-Mail. Dieser Service ist für Sie kostenlos und kann jederzeit abbestellt werden.

Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.